HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Epicatechin-3-Gallate Signaling and Protection against Cardiac Ischemia/Reperfusion Injury.

Abstract
At concentrations found in humans after ingestion of one to two cups of green tea, epicatechin-3-gallate (ECG) modulates Na/K-ATPase conformation and activity. Akin to ouabain, an archetypal Na/K-ATPase ligand of the cardiotonic steroid (CTS) family, ECG also activates protein kinase C epsilon type (PKCε) translocation and increases the force of contraction of the rat heart. This study evaluated whether, like ouabain, ECG also modulates Na/K-ATPase/Src receptor function and triggers pre- and postconditioning against ischemia/reperfusion (I/R) injury. In vitro, ECG activated the purified Na/K-ATPase/Src complex. In Langendorff-perfused rat hearts, submicromolar concentrations of ECG administered either before or after ischemia reduced infarct size by more than 40%, decreased lactate dehydrogenase release, and improved the recovery of cardiac function. ECG protection was blocked by PKCε inhibition and attenuated by mitochondrial KATP channel inhibition. In a unique mammalian cell system with depleted Na/K-ATPase α1 expression, ECG-induced PKCε activation persisted but protection against I/R was blunted. Taken together, these results reveal a Na/K-ATPase- and PKCε-dependent mechanism of protection by ECG that is also distinct from the mechanism of action of ouabain. These ECG properties likely contribute to the positive impact of green tea consumption on cardiovaascular health and warrant further investigation into the role of cardiac Na/K-ATPase signaling in the cardioprotective effect of green tea consumption. SIGNIFICANCE STATEMENT: Consumption of green tea, the richest dietary source of ECG, is associated with a reduced risk of cardiac mortality. Antioxidant effects of ECG and other tea polyphenols are well known, but reported for concentrations well above dietary levels. Therefore, the mechanism underlying the cardioprotective effect of green tea remains incompletely understood. This study provides experimental evidence that ECG concentrations commonly detected in humans after consumption of a cup of tea trigger the Na/K-ATPase/Src receptor in a cell-free system, activate a CTS-like signaling pathway, and provide PKCε-dependent protection against ischemia/reperfusion injury in rat hearts. Mechanistic studies in mammalian cells with targeted Na/K-ATPase depletion revealed that although Na/K-ATPase does not mediate ECG-induced PKCε activation, it is required for ECG-induced protection against ischemia/reperfusion injury.
AuthorsYiyao Qi, Changjun Yang, Zhen Jiang, Yin Wang, Feng Zhu, Tao Li, Xiaochun Wan, Yunhui Xu, Zijian Xie, Daxiang Li, Sandrine V Pierre
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 371 Issue 3 Pg. 663-674 (12 2019) ISSN: 1521-0103 [Electronic] United States
PMID31582423 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.
Chemical References
  • Plant Extracts
  • Potassium Channels
  • Tea
  • mitochondrial K(ATP) channel
  • Catechin
  • epicatechin gallate
  • Prkce protein, rat
  • Protein Kinase C-epsilon
  • Sodium-Potassium-Exchanging ATPase
Topics
  • Animals
  • Catechin (analogs & derivatives, pharmacology)
  • Cells, Cultured
  • Male
  • Myocardial Reperfusion Injury (prevention & control)
  • Plant Extracts (pharmacology)
  • Potassium Channels (physiology)
  • Protein Kinase C-epsilon (physiology)
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction (drug effects)
  • Sodium-Potassium-Exchanging ATPase (metabolism)
  • Swine
  • Tea

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: